The US Market for Rx to OTC Switches, 2015 Edition - Analysis of the $7.8 Billion Industry

DUBLIN, Feb. 23, 2015 /PRNewswire/ --Research and Markets

(http://www.researchandmarkets.com/research/rn97w3/the_us_market_for) has announced the addition of the "The US Market for Rx to OTC Switches, 7th Edition" report to their offering.

Over the past 38 years the U.S. Rx-to-OTC market has grown into a $7.8 billion market

This has mainly been due to factors such as patent expirations, increasing competitiveness with the pharmaceutical environment, brand re-invention, consumer demand, and cost containment strategies. The U.S. market for Rx-to-OTC Switches encompasses a wide variety of products that have been determined safe and effective as over-the-counter products, once only available by prescription.

The current climate of patient-consumer awareness of health issues is continuing to influence the Rx-to-OTC market. Consumers are more prepared to take responsibility for their own health and are willing to purchase medicines over the counter. An increased focus on cost-savings, coupled with the effects of advertising and promotion, result a higher rate of OTC purchases. Aging baby boomers, many of which are taking greater interest in their health, have created a growing Rx-to-OTC industry in America. It is anticipated that Rx-to-OTC switch products will continue to grow as interest from both consumers and developers continue to expand.

The U.S. Market for Rx-to-OTC Switches focuses on several treatment segments in which Rx-to-OTC switches are available. These include:

• Allergy, Cough, Cold, and Sinus Products
• Analgesics, NSAIDs, and Pain Treatments
• Anti-Infectives
• Gastrointestinal Drugs
• Hair Loss Products
• Hormones
• Oral Care
• Overactive Bladder
• Rectal Ointments
• Sleep-aids
• Smoking Cessation
• Weight Loss

In addition to the areas with switches in place, this report has identified other areas which may be open to Rx-to-OTC switches in the future.

These include:

• Blood Products
• BPH Treatments
• Cholesterol-reducing Drugs
• Hormone Replacement Therapies
• Migraine Treatments
• Opioid Overdose Treatment
• Osteoporosis Treatments
• Sexual Dysfunction/ Erectile Dysfunction

Key Topics Covered:

1. Executive Summary
2. The Otc Drug Industry
3. Allergy, Cough, Cold, And Sinus Products
4. Analgesics And Other Pain Relievers
5. Anti-Infectives
6. Gastrointestinal Drugs
7. Smoking Cessation Products
8. Other Drug Classifications
9. Profiles For Major Rx-To-Otc Participants
10. Company Directory
11. List Of Exhibits
12. Executive Summary

Companies Featured:

• Bayer
• Boehringer Ingelheim
• GlaxoSmithKline
• Johnson & Johnson
• Novartis
• Perrigo Company
• Pfizer
• Prestige Brands
• Procter & Gamble
• Reckitt Benckiser
• Sanofi/Chattem
• TEVA

For more information visit http://www.researchandmarkets.com/research/rn97w3/the_us_market_for

Media Contact: Laura Wood , [phone], [e-mail]